Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3448363 Title: NOUVELLE COMPOSITION PHARMACEUTIQUE COMPRENANT DES PARTICULES COMPRENANT UN COMPLEXE D'UN POLYRIBONUCLÉOTIDE DOUBLE BRIN ET UNE POLYALKYLÈNEIMINE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
178041489
WO application number:
EP2017079688
Type:
European patent granted for BE
Status:
Open
Publication number:
3448363
WO publication number:
WO2018210439
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
17/11/2017
Grant date:
11/05/2022
EP publication date:
06/03/2019
WO publication date:
22/11/2018
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
11/05/2022
EP B1 publication date:
11/05/2022
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
17/11/2037

Applicant

Name:
Highlight Therapeutics, S.L.
Legal Form:
From:
11/05/2022
Address:
Parque Cientifico de la Universidad de Valencia (PCUV) C/ Catedratico Augustin Escardino 9, 46980 Paterna, Spain (ES)
To:

Agent

Name:
GRUND Martin
Legal Form:
From:
13/07/2022
Address:
Steinsdorfstrasse 2, 80538, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
QUINTERO ORTIZ, Marisol
Legal Form:
Address:
46980 Paterna, Spain (ES)

2

Name:
POZUELO RUBIO, Mercedes
Legal Form:
Address:
46980 Paterna, Spain (ES)

3

Name:
PLANELLES CARAZO, Lourdes
Legal Form:
Address:
46980 Paterna, Spain (ES)

Priority

1

Priority patent number:
17200469
Priority date:
07/11/2017
Priority country:
European Patent Office (EPO) (EP)

2

Priority patent number:
17382301
Priority date:
26/05/2017
Priority country:
European Patent Office (EPO) (EP)

3

Priority patent number:
17171617
Priority date:
17/05/2017
Priority country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 9/08; A61K 31/713; A61K 47/59; A61P 35/00;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2022/09
Publication date:
20/05/2022
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

1

Issue number:
202219
Publication date:
11/05/2022
Description:
Grant (B1)

2

Issue number:
202224
Publication date:
15/06/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
01/12/2025
Annual fee number:
9
Annual fee amount:
165 Euro
Expected payer:
Last annual fee payment date:
20/11/2024
Last annual fee paid number:
8
Last annual fee paid amount:
135 Euro
Payer:
DENNEMEYER & Co S.A.R.L.
Filing date Document type Publication Type Document Description Number of pages File Type
13/07/2022 Incoming Correspondence (Post) 1 PDF /4/2/4/5/2/0722225424/docs/178041489_0_incomingcorrespondencepaper_20220714_082531077.pdf